Uni-hemispheric dual-site anodal tDCS (M1-DLPFC) for upper limb motor function and spasticity in chronic stroke: a randomized clinical trial

单侧半球双位点阳极经颅直流电刺激(M1-DLPFC)治疗慢性卒中患者上肢运动功能和痉挛:一项随机临床试验

阅读:2

Abstract

BACKGROUND/OBJECTIVES: Upper extremity impairment significantly affects motor function and quality of life after stroke. This study investigated the safety and efficacy of a non-invasive brain stimulation approach, uni-hemispheric concurrent dual-site anodal transcranial direct current stimulation (a-tDCS) targeting the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC), to improve upper extremity performance in chronic stroke. METHODS: This double-blind, randomized, sham-controlled study involved 38 chronic stroke patients to evaluate the safety and efficacy of uni-hemispheric concurrent dual-site anodal transcranial direct current stimulation (a-tDCS). Participants were randomly assigned to one of two groups: experimental group 1 (a-tDCS at 2 mA targeting M1 and DLPFC concurrently) or experimental group 2 (active a-tDCS at 2 mA over M1 with sham stimulation over DLPFC), with each receiving 20-min sessions over five consecutive days. Upper extremity motor function (Fugl-Meyer Assessment-FMA) and spasticity (Modified Modified Ashworth Scale-MMAS) were assessed at baseline and 24 h following the final intervention. The procedure was deemed safe. Statistical analysis involved the U Mann-Whitney test for between-group comparisons and the Wilcoxon signed-rank test for within-group changes. RESULTS: The results demonstrated that uni-hemispheric concurrent dual-site a-tDCS targeting M1 and DLPFC in experimental group 1 did not lead to statistically significant improvements in upper extremity motor function, elbow and wrist flexor spasticity, or range of motion in this cohort of chronic stroke patients. Furthermore, no statistically significant differences were found between experimental group 1 and experimental group 2 (the sham control group) for any of the measured outcomes (p ≥ 0.05). CONCLUSION: Uni-hemispheric concurrent dual-site a-tDCS targeting both M1 and DLPFC did not demonstrate a superior effect on upper extremity motor recovery compared to a-tDCS applied solely to M1 in chronic stroke patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。